{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["angiogenesis", "molecular docking", "polyherbal formulation", "triphala churna"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31979409", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "23"}], "Language": ["eng"], "ELocationID": ["177", "10.3390/biom10020177"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "10", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "23"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Multiple Targets Directed Multiple Ligands: An In Silico and In Vitro Approach to Evaluating the Effect of Triphala on Angiogenesis.", "Abstract": {"AbstractText": ["Angiogenesis is critical in both physiological and pathological conditions and targeting angiogenesis is a promising strategy for the development of therapies against cancer; however, cells develop resistance to anti-angiogenic therapy, necessitating a more effective strategy. Natural medicines have been used in anti-cancer therapy for many years, but the mechanisms behind these have not generally been explored. Triphala churna (THL), an Indian ayurvedic herbal formulation made from the dried fruits of three medicinal plants, is used as a herbal drug for the treatment of various diseases, including cancer. THL contains over fifteen phytochemicals with different pharmacological effects, especially inhibition of tumor progression. In this study, we examined the effect of these compounds against different targets using docking and in vitro studies. Results showed that THL has a prediction efficacy of (-436.7), and it inhibited angiogenesis by blocking multiple components of the VEGF/VEGFR2 signaling pathway. The anti-angiogenic effect was mediated by the combined effect of the two top ranked phytochemicals, punicalagin (-424.8) and chebulagic acid (-414.8). The new approach developed in this study to determine the potential efficacy of herbal formulation could be a useful strategy to assess the efficacy of different herbal formulations."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Computational Biology and Bioinformatics, University of Kerala, Thiruvananthapuram, Kerala, India."}], "LastName": "Abhinand", "ForeName": "Chandran S", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inter-University Centre for Genomics and Gene Technology, University of Kerala, Thiruvananthapuram, Kerala, India."}], "LastName": "Athira", "ForeName": "Prabhakaran A", "Initials": "PA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inter-University Centre for Genomics and Gene Technology, University of Kerala, Thiruvananthapuram, Kerala, India."}], "LastName": "Soumya", "ForeName": "Sasikumar J", "Initials": "SJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Computational Biology and Bioinformatics, University of Kerala, Thiruvananthapuram, Kerala, India."}, {"Identifier": [], "Affiliation": "Inter-University Centre for Genomics and Gene Technology, University of Kerala, Thiruvananthapuram, Kerala, India."}], "LastName": "Sudhakaran", "ForeName": "Perumana R", "Initials": "PR"}], "GrantList": [{"GrantID": "001/FSHP/12/CSTE", "Agency": "Kerala State Council for Science, Technology and Environment", "Country": "International"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzopyrans"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrolyzable Tannins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "VEGFA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Endothelial Growth Factor A"}, {"RegistryNumber": "0", "NameOfSubstance": "triphala"}, {"RegistryNumber": "23094-71-5", "NameOfSubstance": "chebulagic acid"}, {"RegistryNumber": "65995-63-3", "NameOfSubstance": "punicalagin"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "KDR protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Vascular Endothelial Growth Factor Receptor-2"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzopyrans"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucosides"}, {"QualifierName": [], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hydrolyzable Tannins"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Medicine, Ayurvedic"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Vascular Endothelial Growth Factor A"}, {"QualifierName": ["metabolism"], "DescriptorName": "Vascular Endothelial Growth Factor Receptor-2"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Oklu R., Walker T.G., Wicky S., Hesketh R. Angiogenesis and current antiangiogenic strategies for the treatment of cancer. J. Vasc. Interv. Radiol. 2010;21:1791\u20131805. doi: 10.1016/j.jvir.2010.08.009.", "ArticleIdList": ["10.1016/j.jvir.2010.08.009", "20980167"]}, {"Citation": "Moserle L., Casanovas O. Anti-angiogenesis and metastasis: A tumor and stromal cell alliance. J. Intern. Med. 2013;273:128\u2013137. doi: 10.1111/joim.12018.", "ArticleIdList": ["10.1111/joim.12018", "23198797"]}, {"Citation": "Dor Y., Porat R., Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am. J. Physiol. Cell Physiol. 2001;280:367\u2013374. doi: 10.1152/ajpcell.2001.280.6.C1367.", "ArticleIdList": ["10.1152/ajpcell.2001.280.6.C1367", "11350731"]}, {"Citation": "Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009;21:154\u2013165. doi: 10.1016/j.ceb.2008.12.012.", "ArticleIdList": ["10.1016/j.ceb.2008.12.012", "19230644"]}, {"Citation": "Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964\u20133968.", "ArticleIdList": ["7664263"]}, {"Citation": "Moghaddam S.M., Amini A., Morris D.L., Pourgholami M.H. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev. 2012;31:143\u2013162. doi: 10.1007/s10555-011-9337-5.", "ArticleIdList": ["10.1007/s10555-011-9337-5", "PMC3350632", "22101807"]}, {"Citation": "Ferrara N. VEGF and the quest for tumor angiogenesis factors. Nat. Rev. Cancer. 2002;2:795\u2013803. doi: 10.1038/nrc909.", "ArticleIdList": ["10.1038/nrc909", "12360282"]}, {"Citation": "Sagar S.M., Yance D., Wong R.K. Natural health products that inhibit angiogenesis: A potential source for investigational new agents to treat cancer-Part 1. Curr. Oncol. 2006;13:14\u201326.", "ArticleIdList": ["PMC1891166", "17576437"]}, {"Citation": "Abhinand C.S., Raju R., Soumya S.J., Arya P.S., Sudhakaran P.R. VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J. Cell Commun. Signal. 2016;10:347\u2013354. doi: 10.1007/s12079-016-0352-8.", "ArticleIdList": ["10.1007/s12079-016-0352-8", "PMC5143324", "27619687"]}, {"Citation": "Lu K., Basu S. The natural compound chebulagic acid inhibits vascular endothelial growth factor A mediated regulation of endothelial cell functions. Sci. Rep. 2015;10:9642. doi: 10.1038/srep09642.", "ArticleIdList": ["10.1038/srep09642", "PMC4819393", "25859636"]}, {"Citation": "Singh D.P., Govindarajan R., Rawat A.K. High-performance liquid chromatography as a tool for the chemical standardisation of Triphala\u2014an Ayurvedic formulation. Phytochem. Anal. 2008;19:164\u2013168. doi: 10.1002/pca.1032.", "ArticleIdList": ["10.1002/pca.1032", "17879225"]}, {"Citation": "Pawar V., Lahorkar P., Anantha Narayana D.B. Development of a RP-HPLC Method for Analysis of Triphala Curna and its Applicability to Test Variations in Triphala Curna Preparations. Indian J. Pharm. Sci. 2009;71:382\u2013386. doi: 10.4103/0250-474X.57286.", "ArticleIdList": ["10.4103/0250-474X.57286", "PMC2865809", "20502543"]}, {"Citation": "Baliga M.S. Triphala, Ayurvedic formulation for treating and preventing cancer: A review. J. Altern. Complement. Med. 2010;16:1301\u20131308. doi: 10.1089/acm.2009.0633.", "ArticleIdList": ["10.1089/acm.2009.0633", "21138390"]}, {"Citation": "Lu K., Chakroborty D., Sarkar C., Lu T., Xie Z., Liu Z., Basu S. Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis. PLoS ONE. 2012;7:43934. doi: 10.1371/journal.pone.0043934.", "ArticleIdList": ["10.1371/journal.pone.0043934", "PMC3427174", "22937129"]}, {"Citation": "Athira A.P., Helen A., Saja K., Reddanna P., Sudhakaran P.R. Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor. Int. J. Vasc. Med. 2013:843897. doi: 10.1155/2013/843897.", "ArticleIdList": ["10.1155/2013/843897", "PMC3833124", "24288615"]}, {"Citation": "Reddy D.B., Reddy T.C., Jyotsna G., Sharan S., Priya N., Lakshmipathi V., Reddanna P. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J. Ethnopharmacol. 2009;124:506\u2013512. doi: 10.1016/j.jep.2009.05.022.", "ArticleIdList": ["10.1016/j.jep.2009.05.022", "19481594"]}, {"Citation": "Athira A.P., Abhinand C.S., Saja K., Helen A., Reddanna P., Sudhakaran P.R. Anti-angiogenic effect of chebulagic acid involves inhibition of the VEGFR2- and GSK-3\u03b2-dependent signaling pathways. Biochem. Cell Biol. 2017;95:563\u2013570. doi: 10.1139/bcb-2016-0132.", "ArticleIdList": ["10.1139/bcb-2016-0132", "28467858"]}, {"Citation": "Sandhya T., Lathika K.M., Pandey B.N., Mishra K.P. Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett. 2006;231:206\u2013214. doi: 10.1016/j.canlet.2005.01.035.", "ArticleIdList": ["10.1016/j.canlet.2005.01.035", "15899544"]}, {"Citation": "Gu J., Chen L., Yuan G., Xu X. A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes Mellitus. Evid. Based Complement. Alternat. Med. 2013:203614. doi: 10.1155/2013/203614.", "ArticleIdList": ["10.1155/2013/203614", "PMC3810496", "24223610"]}, {"Citation": "Kiran M.S., Sameer Kumar V.B., Viji R.I., Sudhakaran P.R. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol. Int. 2006;30:704\u2013713. doi: 10.1016/j.cellbi.2006.05.001.", "ArticleIdList": ["10.1016/j.cellbi.2006.05.001", "16829143"]}, {"Citation": "Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007;2:329\u2013333. doi: 10.1038/nprot.2007.30.", "ArticleIdList": ["10.1038/nprot.2007.30", "17406593"]}, {"Citation": "Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:871\u2013874. doi: 10.1016/0019-2791(71)90454-X.", "ArticleIdList": ["10.1016/0019-2791(71)90454-X", "5135623"]}, {"Citation": "Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265\u2013275.", "ArticleIdList": ["14907713"]}, {"Citation": "Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 1979;76:4350\u20134354. doi: 10.1073/pnas.76.9.4350.", "ArticleIdList": ["10.1073/pnas.76.9.4350", "PMC411572", "388439"]}, {"Citation": "Karar J., Maity A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front. Mol. Neurosci. 2011;4:51. doi: 10.3389/fnmol.2011.00051.", "ArticleIdList": ["10.3389/fnmol.2011.00051", "PMC3228996", "22144946"]}, {"Citation": "Koch S., Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2012;2:a006502. doi: 10.1101/cshperspect.a006502.", "ArticleIdList": ["10.1101/cshperspect.a006502", "PMC3385940", "22762016"]}, {"Citation": "Zhao X., Guan J.L. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv. Drug Deliv. Rev. 2011;63:610\u2013615. doi: 10.1016/j.addr.2010.11.001.", "ArticleIdList": ["10.1016/j.addr.2010.11.001", "PMC3132829", "21118706"]}, {"Citation": "Yu J., Bian D., Mahanivong C., Cheng R.K., Zhou W., Huang S. p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J. Biol. Chem. 2004;279:50446\u201350454. doi: 10.1074/jbc.M409221200.", "ArticleIdList": ["10.1074/jbc.M409221200", "15371454"]}, {"Citation": "Mor F., Quintana F.J., Cohen I.R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J. Immunol. 2004;172:4618\u20134623. doi: 10.4049/jimmunol.172.7.4618.", "ArticleIdList": ["10.4049/jimmunol.172.7.4618", "15034080"]}, {"Citation": "Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860\u2013867. doi: 10.1038/nature01322.", "ArticleIdList": ["10.1038/nature01322", "PMC2803035", "12490959"]}, {"Citation": "Todoric J., Antonucci L., Karin M. Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prev. Res. (Phila) 2016;9:895\u2013905. doi: 10.1158/1940-6207.CAPR-16-0209.", "ArticleIdList": ["10.1158/1940-6207.CAPR-16-0209", "PMC5142754", "27913448"]}, {"Citation": "Rasool M., Sabina E.P. Antiinflammatory effect of the Indian Ayurvedic herbal formulation Triphala on adjuvant-induced arthritis in mice. Phytother. Res. 2007;21:889\u2013894. doi: 10.1002/ptr.2183.", "ArticleIdList": ["10.1002/ptr.2183", "17533629"]}, {"Citation": "Kalaiselvan S., Rasool M. Triphala exhibits anti-arthritic effect by ameliorating bone and cartilage degradation in adjuvant-induced arthritic rats. Immunol. Invest. 2015;44:411\u2013426. doi: 10.3109/08820139.2015.1017047.", "ArticleIdList": ["10.3109/08820139.2015.1017047", "25942351"]}, {"Citation": "Yang M.H., Ali Z., Khan I.A., Khan S.I. Anti-inflammatory activity of constituents isolated from Terminalia chebula. Nat. Prod. Commun. 2014;9:965\u2013968. doi: 10.1177/1934578X1400900721.", "ArticleIdList": ["10.1177/1934578X1400900721", "25230505"]}, {"Citation": "BenSaad L.A., Kim K.H., Quah C.C., Kim W.R., Shahimi M. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement. Altern. Med. 2017;17:47. doi: 10.1186/s12906-017-1555-0.", "ArticleIdList": ["10.1186/s12906-017-1555-0", "PMC5237561", "28088220"]}, {"Citation": "Loizou S., Lekakis I., Chrousos G.P., Moutsatsou P. Beta-sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol. Nutr. Food Res. 2010;54:551\u2013558. doi: 10.1002/mnfr.200900012.", "ArticleIdList": ["10.1002/mnfr.200900012", "19937850"]}, {"Citation": "Rabelo T.K., Guimar\u00e3es A.G., Oliveira M.A., Gasparotto J., Serafini M.R., de Souza Ara\u00fajo A.A., Quintans-J\u00fanior L.J., Moreira J.C.F., Gelain D.P. Shikimic acid inhibits LPS-induced cellular pro-inflammatory cytokines and attenuates mechanical hyperalgesia in mice. Int. Immunopharmacol. 2016;39:97\u2013105. doi: 10.1016/j.intimp.2016.07.016.", "ArticleIdList": ["10.1016/j.intimp.2016.07.016", "27454847"]}, {"Citation": "Huang L., Guan T., Qian Y., Huang M., Tang X., Li Y., Sun H. Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B. Eur. J. Pharmacol. 2011;672:169\u2013174. doi: 10.1016/j.ejphar.2011.09.175.", "ArticleIdList": ["10.1016/j.ejphar.2011.09.175", "21970807"]}, {"Citation": "Jin F., Cheng D., Tao J.Y., Zhang S.L., Pang R., Guo Y.J., Ye P., Dong J.H., Zhao L. Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis. BMC Gastroenterol. 2013;13:79. doi: 10.1186/1471-230X-13-79.", "ArticleIdList": ["10.1186/1471-230X-13-79", "PMC3655894", "23641818"]}, {"Citation": "Jang S.A., Park D.W., Kwon J.E., Song H.S., Park B., Jeon H., Sohn E.H., Koo H.J., Kang S.C. Quinic acid inhibits vascular inflammation in TNF-\u03b1-stimulated vascular smooth muscle cells. Biomed. Pharmacother. 2017;96:563\u2013571. doi: 10.1016/j.biopha.2017.10.021.", "ArticleIdList": ["10.1016/j.biopha.2017.10.021", "29032340"]}, {"Citation": "DeLisser H.M., Christofidou-Solomidou M., Strieter R.M., Burdick M.D., Robinson C.S., Wexler R.S., Kerr J.S., Garlanda C., Merwin J.R., Madri J.A., et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol. 1997;151:671\u2013677.", "ArticleIdList": ["PMC1857836", "9284815"]}, {"Citation": "Nishiwaki Y., Yoshida M., Iwaguro H., Masuda H., Nitta N., Asahara T., Isobe M. Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 2007;27:512\u2013518. doi: 10.1161/01.ATV.0000254812.23238.2b.", "ArticleIdList": ["10.1161/01.ATV.0000254812.23238.2b", "17170379"]}, {"Citation": "Lamalice L., Le Boeuf F., Huot J. Endothelial cell migration during angiogenesis. Circ. Res. 2007;100:782\u2013794. doi: 10.1161/01.RES.0000259593.07661.1e.", "ArticleIdList": ["10.1161/01.RES.0000259593.07661.1e", "17395884"]}, {"Citation": "Ucuzian A.A., Gassman A.A., East A.T., Greisler H.P. Molecular mediators of angiogenesis. J. Burn Care Res. 2010;31:158\u2013175. doi: 10.1097/BCR.0b013e3181c7ed82.", "ArticleIdList": ["10.1097/BCR.0b013e3181c7ed82", "PMC2818794", "20061852"]}, {"Citation": "Ribatti D. Tumor refractoriness to anti-VEGF therapy. Oncotarget. 2016;7:46668\u201346677. doi: 10.18632/oncotarget.8694.", "ArticleIdList": ["10.18632/oncotarget.8694", "PMC5216828", "27081695"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "6"}, {"Year": "2020", "Month": "1", "Day": "14"}, {"Year": "2020", "Month": "1", "Day": "16"}, {"Year": "2020", "Month": "1", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31979409", "PMC7072423", "10.3390/biom10020177", "biom10020177"]}}]}